Clonal origin and spread of metastatic prostate cancer

被引:31
|
作者
van Etten, Jamie L. [1 ]
Dehm, Scott M. [1 ,2 ,3 ]
机构
[1] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA
[2] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Urol, Minneapolis, MN USA
关键词
metastasis; prostate; endocrine therapy resistance; cell lineage/genetics; clonal spread; COPY-NUMBER ANALYSIS; ACTIVE ANDROGEN RECEPTOR; MUTATIONAL LANDSCAPE; MOLECULAR ANALYSIS; MONOCLONAL ORIGIN; SPLICE VARIANTS; HETEROGENEITY; EVOLUTION; PROGRESSION; RESISTANCE;
D O I
10.1530/ERC-16-0049
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastatic disease is responsible for the majority of prostate cancer deaths. The standard treatment for metastatic disease is surgical or chemical castration in the form of androgen deprivation therapy. Despite initial success and disease regression, resistance to therapy ultimately develops and the disease transitions to castration-resistant prostate cancer, which is uniformly fatal. Thus, developing an understanding of genetic evolution in metastasis and in response to therapy has been a focus of recent studies. Large-scale sequencing studies have provided an expansive catalog of the mutation events that occur in the prostate cancer genome at various stages of disease progression. Small-scale studies have interrogated the genomic composition of multiple metastatic sites within individual patients or have tracked clonal evolution longitudinally in tissues, circulating tumor cells, or circulating tumor DNA. Collectively, these efforts have provided a new conceptual framework for understanding the origin of prostate cancer, as well as the origin and evolution of metastatic disease. In this review, we highlight these recent insights into the spatiotemporal landscape of genetic evolution of prostate cancer.
引用
收藏
页码:R207 / R217
页数:11
相关论文
共 50 条
  • [31] CLONAL ORIGIN OF BLADDER-CANCER
    SIDRANSKY, D
    FROST, P
    VONESCHENBACH, A
    OYASU, R
    PREISINGER, AC
    VOGELSTEIN, B
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (11): : 737 - 740
  • [32] Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
    Liu, Wennuan
    Laitinen, Sari
    Khan, Sofia
    Vihinen, Mauno
    Kowalski, Jeanne
    Yu, Guoqiang
    Chen, Li
    Ewing, Charles M.
    Eisenberger, Mario A.
    Carducci, Michael A.
    Nelson, William G.
    Yegnasubramanian, Srinivasan
    Luo, Jun
    Wang, Yue
    Xu, Jianfeng
    Isaacs, William B.
    Visakorpi, Tapio
    Bova, Steven
    NATURE MEDICINE, 2009, 15 (05) : 559 - 565
  • [33] Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
    Wennuan Liu
    Sari Laitinen
    Sofia Khan
    Mauno Vihinen
    Jeanne Kowalski
    Guoqiang Yu
    Li Chen
    Charles M Ewing
    Mario A Eisenberger
    Michael A Carducci
    William G Nelson
    Srinivasan Yegnasubramanian
    Jun Luo
    Yue Wang
    Jianfeng Xu
    William B Isaacs
    Tapio Visakorpi
    G Steven Bova
    Nature Medicine, 2009, 15 : 559 - 565
  • [34] Clonal evolution during metastatic spread in high-risk neuroblastoma
    Gundem, Gunes
    Levine, Max F.
    Roberts, Stephen S.
    Cheung, Irene Y.
    Medina-Martinez, Juan S.
    Feng, Yi
    Arango-Ossa, Juan E.
    Chadoutaud, Loic
    Rita, Mathieu
    Asimomitis, Georgios
    Zhou, Joe
    You, Daoqi
    Bouvier, Nancy
    Spitzer, Barbara
    Solit, David B.
    Dela Cruz, Filemon
    LaQuaglia, Michael P.
    Kushner, Brian H.
    Modak, Shakeel
    Shukla, Neerav
    Iacobuzio-Donahue, Christine A.
    Kung, Andrew L.
    Cheung, Nai-Kong V.
    Papaemmanuil, Elli
    NATURE GENETICS, 2023, 55 (06) : 1022 - +
  • [35] Clonal evolution during metastatic spread in high-risk neuroblastoma
    Gunes Gundem
    Max F. Levine
    Stephen S. Roberts
    Irene Y. Cheung
    Juan S. Medina-Martínez
    Yi Feng
    Juan E. Arango-Ossa
    Loic Chadoutaud
    Mathieu Rita
    Georgios Asimomitis
    Joe Zhou
    Daoqi You
    Nancy Bouvier
    Barbara Spitzer
    David B. Solit
    Filemon Dela Cruz
    Michael P. LaQuaglia
    Brian H. Kushner
    Shakeel Modak
    Neerav Shukla
    Christine A. Iacobuzio-Donahue
    Andrew L. Kung
    Nai-Kong V. Cheung
    Elli Papaemmanuil
    Nature Genetics, 2023, 55 : 1022 - 1033
  • [36] Metastatic Prostate Cancer
    Hampton, Tracy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (13): : 1245 - 1245
  • [37] Metastatic Prostate Cancer
    Sartor, Oliver
    de Bono, Johann S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (07): : 645 - 657
  • [38] METASTATIC PROSTATE CANCER
    Bulsari, Krupali
    Vaishnav, Manan
    Sharma, Sharad
    INTERNAL MEDICINE JOURNAL, 2014, 44 : 27 - 27
  • [39] Dissection of primary prostate cancer to determine the clonal origin of synchronous lymph node metastasis.
    Nallandhighal, Srinivas
    Tosoian, Jeffrey J.
    Singhal, Udit
    Karim, Razeen
    Mathieu, Romain
    Plouffe, Komal
    Rioux-Leclercq, Nathalie
    Siddiqui, Javed
    Liu, Chia-Jen
    Hovelson, Daniel H.
    Doglioni, Claudio
    Morgan, Todd Matthew
    Susani, Martin
    Luciano, Roberta Luciano
    Shariat, Shahrokh F.
    Tomlins, Scott A.
    Briganti, Alberto
    Palapattu, Ganesh S.
    Udager, Aaron M.
    Salami, Simpa Samuel
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] RETROPERITONEAL METASTATIC SPREAD OF OVARIAN CANCER
    CREASMAN, WT
    ABUGHAZALEH, S
    SCHMIDT, HJ
    GYNECOLOGIC ONCOLOGY, 1978, 6 (05) : 447 - 450